Literature DB >> 3117701

Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.

A Bauernfeind1, K Rotter, C Weisslein-Pfister.   

Abstract

The identification of respiratory pathogens (e. g. Haemophilus influenzae, Streptococcus pneumoniae) is impaired by the presence of large quantities of Pseudomonas aeruginosa, as is the case in the sputum specimens of cystic fibrosis patients. A procedure has been evaluated whereby the selective inhibition of the proliferation of P. aeruginosa is achieved by a broad spectrum pyocin, whereas the growth of H. influenzae is not influenced. This technique has been tested over a two year period resulting in a significantly augmented rate of identification of H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117701     DOI: 10.1007/bf01644138

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

1.  Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.

Authors:  D E Roberts; P Cole
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

2.  Haemophilus infections in cystic fibrosis.

Authors:  R H George; A P Gillett; C A Roycroft
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

3.  Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Authors:  A Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

  3 in total
  6 in total

1.  Treatment of infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  Infection       Date:  1987       Impact factor: 3.553

2.  Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Authors:  A Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

Review 3.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis.

Authors:  L V Möller; G J Ruijs; H G Heijerman; J Dankert; L van Alphen
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

5.  A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.

Authors:  Alexander Chuchalin; Eszter Csiszér; Kàlmàn Gyurkovics; Maria Trawińska Bartnicka; Dorota Sands; Nikolai Kapranov; Guido Varoli; Pier Alessandro Monici Preti; Henryk Mazurek
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Authors:  Gerard Lenoir; Yuriy Genadievich Antypkin; Angelo Miano; Paolo Moretti; Maurizio Zanda; Guido Varoli; Pier Alessandro Monici Preti; Nikolay Leonidovich Aryayev
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.